Filing Details

Accession Number:
0001209191-21-020006
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-11 21:00:19
Reporting Period:
2021-03-09
Accepted Time:
2021-03-11 21:00:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1420800 Colfax Corp CFX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1205249 A Daniel Pryor 420 National Business Parkway
5Th Floor
Annapolis Junction MD 20701
Evp, Strategy & Business Dev. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $.001 Acquisiton 2021-03-09 21,689 $0.00 145,035 No 4 A Direct
Common Stock, Par Value $.001 Acquisiton 2021-03-09 55,284 $0.00 200,319 No 4 A Direct
Common Stock, Par Value $.001 Disposition 2021-03-10 4,004 $47.42 196,315 No 4 S Direct
Common Stock, Par Value $.001 Disposition 2021-03-10 6,157 $47.92 190,158 No 4 S Direct
Common Stock, Par Value $.001 Disposition 2021-03-10 5,500 $47.27 184,658 No 4 S Direct
Common Stock, Par Value $.001 Disposition 2021-03-10 20,401 $47.86 164,257 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 A Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, Par Value $.001 2,312 Indirect By 401K Plan
Common Stock, Par Value $.001 1,000 Indirect By trust for daughter
Common Stock, Par Value $.001 1,000 Indirect By trust for daughter
Common Stock, Par Value $.001 1,000 Indirect By trust for son
Footnotes
  1. Reflects the certification of the performance criteria for performance-based restricted stock units ("PRSUs") previously awarded in 2018. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2019 Fiscal Year-End" table on page 43 of the Company's 2020 Proxy Statement as filed with the SEC on April 9, 2020.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain PRSUs.
  3. The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.65 to $47.64, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth in footnote (3) to this Form 4.
  4. The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.65 to $48.18, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth in footnote (4) to this Form 4.
  5. The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.53 to $47.52, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth in footnote (5) to this Form 4.
  6. The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.53 to $48.20, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth in footnote (6) to this Form 4.